{"disease":{"id":"intertrigo","name":"intertrigo"},"drugs":{"marketed":[{"drug_id":"chronic-pf-06480605-450-mg-sc-q4w","indication_name":"Moderate to severe intertrigo","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Chronic- PF-06480605 450 mg SC Q4W","generic_name":"chronic-pf-06480605-450-mg-sc-q4w","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"IL-4 receptor alpha subunit","drug_class":"pharmacological class not specified","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"chronic-pf-06480605-450-mg-sc-q4w","indication_name":"Moderate to severe intertrigo in infants and children","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Chronic- PF-06480605 450 mg SC Q4W","generic_name":"chronic-pf-06480605-450-mg-sc-q4w","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"IL-4 receptor alpha subunit","drug_class":"pharmacological class not specified","quality_score":40,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":2,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03824886","title":"Enhancing SKIN Health and Safety in Aged CARE","phase":"NA","overall_status":"COMPLETED","enrollment_count":405,"lead_sponsor_name":"PD Dr. Jan Kottner","has_results":false},{"nct_id":"NCT04325490","title":"Tapioca Starch Stimutex AS, Aloe Barbadensis, Rose Hip Oil, Allantoin Comparing With Topical 1% Hydrocortisone Cream","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Mahidol University","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}